Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Treating hyperprolactinemia can help manage PCOS symptoms.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Zinc is crucial for nutrition, especially in patients with specific health conditions, and requires careful supplementation and monitoring.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Biotin treatment can significantly improve hair loss and motor functions in certain metabolic disorders.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Most patients improved with oral contraceptives, but some needed additional treatment.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The document concludes that a high-protein, low-carb diet can lead to significant weight loss but requires caution and further research.

Obese and lean women with PCOS have different symptoms and need different treatments.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.